Omeros (OMER) Net Shares Issued and Repurchased (2012 - 2026)
Powered by 
Analysis
Omeros (OMER) Net Shares Issued and Repurchased (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.93 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.40 Bn | 77.41 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.94 Bn | 34.84 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.43 Bn | 32.12 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.37 Bn | 27.53 Bn | - | - |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 142,534.00 |
| Dec 31, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.10 Mn |
| Mar 31, 2025 | 63,615.00 |
| Dec 31, 2024 | 3.33 Mn |
| Mar 31, 2024 | 124,317.00 |
| Dec 31, 2023 | 3.15 Mn |
| Mar 31, 2023 | 195,052.00 |
| Dec 31, 2022 | 1.48 Mn |
| Mar 31, 2022 | 189,010.00 |
| Dec 31, 2021 | 833,143.00 |
| Mar 31, 2021 | 69,603.00 |
| Dec 31, 2020 | 950,517.00 |
| Mar 31, 2020 | 1.74 Mn |
| Dec 31, 2019 | 404,097.00 |
| Dec 31, 2018 | 20,000.00 |
| Mar 31, 2013 | 21,580.00 |
| Dec 31, 2012 | 75,690.00 |